Target intelligence / Profile preview

Izumo sperm-egg fusion protein 1 (IZUMO1)-Folate receptor 4 (Juno) protein-protein interface (IZUMO1-JUNO)

Target
IZUMO1-JUNO
Molecular classification
Protein-protein interface, Receptor-ligand complex
01

Overview

The Izumo sperm-egg fusion protein 1 (IZUMO1)-Folate receptor 4 (Juno) protein-protein interface is the essential molecular recognition event that facilitates the fusion of sperm and egg membranes in mammals (Inoue et al., 2005; Bianchi et al., 2014). IZUMO1 is a transmembrane protein of the immunoglobulin superfamily expressed on the surface of mature sperm, while Juno is a GPI-anchored receptor located on the oocyte plasma membrane (Aydin et al., 2016). The physical binding of IZUMO1 to Juno initiates the fusion process; notably, Juno is rapidly shed from the egg surface following fertilization to prevent polyspermy (Bianchi et al., 2014). Because this interaction is highly specific and indispensable for natural conception, it is a major focal point for the development of non-hormonal contraceptives designed to block the interface (Ohto et al., 2016). Additionally, mutations or deficiencies in either protein are associated with cases of unexplained infertility, positioning the interface as a diagnostic biomarker for reproductive health (Jean et al., 2019). Research is currently directed toward identifying small molecules and biologics that can disrupt this protein-protein interaction with high affinity and specificity to provide reversible fertility control.

Other names
IZUMO1-FOLR4 interfaceIzumo sperm-egg fusion protein 1-folate receptor 4 complexSperm-egg fusion interfaceIZUMO1-JUNO complex
02

Mechanism of action

Competitive inhibition of the physical interaction between sperm-surface IZUMO1 and egg-surface JUNO to prevent gamete membrane fusion and fertilization.

03

Biological functions

FertilizationGamete fusionSperm-egg recognitionSexual reproduction
04

Disease associations

InfertilityContraception
05

Safety considerations

Potential cross-reactivity with other folate receptor family members (FOLR1, FOLR2, FOLR3)Ensuring reversibility of contraceptive effectImmunogenicity of protein-based inhibitors
06

Interacting drugs

Experimental anti-IZUMO1 monoclonal antibodies

2 more in the full profile.

07

Biomarkers

IZUMO1 sperm surface expressionJUNO oocyte surface expressionAnti-IZUMO1 antibodies (in immune-mediated infertility)

Beyond the preview

Go deeper on Izumo sperm-egg fusion protein 1 (IZUMO1)-Folate receptor 4 (Juno) protein-protein interface (IZUMO1-JUNO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Izumo sperm-egg fusion protein 1 (IZUMO1)-Folate receptor 4 (Juno) protein-protein interface (IZUMO1-JUNO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call